CARTESIAN THERAPEUTICS, INC.

Analyst Reco. Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
34.72 ^USD	+10.43%		+41.31%	+67.88%

May. 24	Mizuho Securities Starts Cartesian Therapeutics With Buy Rating	MT
May. 22	Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mizuho Securities Starts Cartesian Therapeutics With Buy Rating	May. 24	MT
Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target	Apr. 23	MT
Mizuho Trims Price Target on Selecta Biosciences to $3 From $4, Maintains Buy Rating	23-08-18	MT
Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating	23-08-18	MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $5 From $4, Maintains Buy Rating	23-03-22	MT
Mizuho Securities Adjusts Selecta Biosciences Price Target to $4 From $5, Maintains Buy Rating	23-03-22	MT
Canaccord Genuity Adjusts Selecta Biosciences Price Target to $9 From $10, Maintains Buy Rating	23-01-31	MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $4 From $6, Reiterates Buy Rating	22-06-21	MT
Needham Adjusts Price Target on Selecta Biosciences to $5 From $6, Reiterates Buy Rating	22-06-14	MT
SVB Securities Initiates Selecta Biosciences at Outperform With $7 Price Target	22-06-06	MT
SELECTA BIOSCIENCES : BTIG Starts Selecta Biosciences at Buy With $10 Price Target	21-06-15	MT
SELECTA BIOSCIENCES : William Blair Upgrades Selecta Biosciences to Outperform from Market Perform	21-03-12	MT
SELECTA BIOSCIENCES : Mizuho Upgrades Selecta Biosciences to Buy From Neutral, Adjusts Price Target to $8 From $2.50	21-01-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer